Famciclovir and celecoxib combination therapy for functional somatic syndromes
AssigneeInnovative Med Concepts, LLC
InventorWilliam L. Pridgen
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of treating fibromyalgia, by administering a therapeutically-effective combination of an antiviral component and a COX-2 inhibitor component. The invention is further related to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound famciclovir and a therapeutically-effective amount of the COX-2 inhibitor celecoxib. The invention is also related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of famciclovir and celecoxib.
Claims16
1-29. (canceled)
A fixed-dose drug combination comprising famciclovir and celecoxib in a dosage amount effective for coacting chronic disease treatment, wherein the amount of famciclovir is present in a unit dosage form to provide a total daily dose in a range from about 500 mg to about 2000 mg, and wherein the amount of celecoxib is present in a unit dosage form to provide a total daily dose in a range from about 300 mg to about 400 mg.
A drug-combination therapy comprising famciclovir and celecoxib in a dosage amount effective for coacting chronic disease treatment, wherein the amount of famciclovir is present in a total daily dose in a range of about 500 mg to about 2000 mg, and wherein the amount of celecoxib is present in a total daily dose in a range of about 300 mg to about 400 mg.
Dependencies are inferred from the claim text.